Ronald Muhlenkamp
Muhlenkamp & Co
Ronald Muhlenkamp HEAT BIOLOGICS, INC stake
total: 197
Muhlenkamp & Co HTBX trades
- Total transactions:
- 3
- New positions:
- 1
- Sold out:
- 1
- Added:
- 1
- Held since:
- 2015 Q2
- Held for:
- 2 quarters
- Latest activity:
- 2015 Q4
According to 2026 Q2 report, Ronald Muhlenkamp doesn't hold any HEAT BIOLOGICS, INC (HTBX) shares. To date, the estimated cost basis is nearly $58.96 for "buy" trades and estimated average "sell" price is $46.3. Muhlenkamp & Co first purchased HTBX in 2015 Q2, initially acquiring 1,000 shares. Since the initial investment in HEAT BIOLOGICS, INC (HTBX), Muhlenkamp & Co has made 2 more transactions.
When did Ronald Muhlenkamp sell HEAT BIOLOGICS, INC (HTBX)?
Ronald Muhlenkamp sold off the entire HEAT BIOLOGICS, INC (HTBX) position in 2015 Q4.
When did Ronald Muhlenkamp buy HEAT BIOLOGICS, INC (HTBX)?
Ronald Muhlenkamp first invested in HEAT BIOLOGICS, INC (HTBX) in 2015 Q2 at the reported quarter-end price of $59.97 per share.
What's the cost basis of Muhlenkamp & Co's HTBX stake?
The estimated cost basis for HEAT BIOLOGICS, INC (HTBX) stake is around $58.96 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $58.96
- Weighted AVG sell price:
- $46.30
Ronald Muhlenkamp's historical trades in HEAT BIOLOGICS, INC
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.